Skip NavigationSkip to Content

Reversal of p53 epigenetic silencing in multiple myeloma permits apoptosis by a p53 activator

  1. Author:
    Hurt, E. M.
    Thomas, S. B.
    Peng, B.
    Farrar, W. L.
  2. Author Address

    NCI, Canc Stem Cell Sect, Lab Canc Prevent, Ctr Canc Res,NIH, Frederick, MD 21702 USA. NCI, Basic Res Program, SAIC Frederick Inc, Frederick, MD 21701 USA. Univ Melbourne, Sch Dent Sci, Melbourne, Vic 3000, Australia.;Farrar, WL, NCI, Canc Stem Cell Sect, Lab Canc Prevent, Ctr Canc Res,NIH, 1050 Boyles St,Bldg 560,Room 31-68, Frederick, MD 21702 USA.;farrar@mail.ncifcrf.gov
    1. Year: 2006
    2. Date: Sep
  1. Journal: Cancer Biology & Therapy
    1. 5
    2. 9
    3. Pages: 1154-1160
  2. Type of Article: Article
  3. ISSN: 1538-4047
  1. Abstract:

    Inactivation of the p53 pathway is a common feature of neoplasia. Dysregulation of the p53 pathway has been shown to involve mutations of p53, increased expression of the p53 inhibitor HDM-2, or epigenetic silencing of the p53 promoter. In multiple myeloma, a neoplasia of terminally differentiated B cells, p53 mutations and deletions are relatively rare and occur in late stage disease. Here, we show that the p53 promoter is hypermethylated in several multiple myeloma cell lines in comparison to normal plasma cells. Two cell lines containing mutant p53, Lp-1 and OPM-2, show a methylation pattern that suggests that they contain one methylated and one unmethylated mutant allele. Two other cell lines, KMS-11 and OPM-2, show hypermethylation of p53 with a lack of expression. In all cell lines tested, treatment with a demethylating agents results in higher expression of p53. Furthermore, following increased expression of p53, treatment of the myeloma cell lines with a p53 activating peptide induces apoptosis. Therefore, combinatorial treatment with demethylating agents followed by delivery of a p53 activating peptide may be an effective therapeutic strategy against multiple myeloma.

    See More

External Sources

  1. WOS: 000242849500031

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel